Perigon Wealth Management’s BeOne Medicines Ltd ONC Stock Holding History

Perigon Wealth Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$727K	Buy	2,551 +14	+0.6%	+$4.13K	0.01%	709
2026 Q1	$753K	Buy	2,537 +39	+2%	+$12.6K	0.01%	623
2025 Q4	$759K	Buy	2,498 +127	+5%	+$41.6K	0.01%	629
2025 Q3	$808K	Sell	2,371 -29	-1%	-$8.81K	0.02%	581
2025 Q2	$581K	Buy	2,400 +21	+0.9%	+$5.15K	0.01%	626
2025 Q1	$647K	Buy	+2,379	New	+$556K	0.02%	568

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Perigon Wealth Management's ONC Position: Q2 2026 in Review

Perigon Wealth Management increased its BeOne Medicines Ltd (ONC) stake by 0.55% in Q2 2026, buying an estimated $4.13K and bringing the position to 2,551 shares worth $727K. The position accounts for 0.01% of the portfolio, ranked #709.

Perigon Wealth Management first reported a position in ONC in Q1 2025 and has held it in 6 quarters since. The position peaked at $808K in Q3 2025. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Perigon Wealth Management held 2,551 shares of BeOne Medicines Ltd worth $727K as of Q2 2026.
Perigon Wealth Management bought 14 BeOne Medicines Ltd shares in Q2 2026, an estimated $4.13K.
BeOne Medicines Ltd made up 0.01% of Perigon Wealth Management's portfolio in Q2 2026, its #709 holding.
Perigon Wealth Management first reported a position in BeOne Medicines Ltd in Q1 2025 and has held it in 6 quarters since.
Perigon Wealth Management's BeOne Medicines Ltd position peaked at $808K in Q3 2025.
283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Perigon Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.